
Thermo Fisher Scientific TMO
€ 408.05
-1.6%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Thermo Fisher Scientific Langfristiger Schuldenstrom 2011-2026 | TMO
Langfristiger Schuldenstrom Jährlich Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 275 M | 261 M | 263 M | 272 M | 266 M | 184 M | 167 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 275 M | 167 M | 241 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Celcuity
CELC
|
54 K | $ 90.27 | -2.38 % | $ 4.22 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 5.31 | -7.9 % | $ 7.06 M | ||
|
Fulgent Genetics
FLGT
|
1.46 M | $ 19.07 | -2.21 % | $ 587 M | ||
|
Castle Biosciences
CSTL
|
1.32 M | $ 21.32 | -1.3 % | $ 618 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
535 K | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
27.7 M | $ 128.48 | -3.44 % | $ 16.1 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
Illumina
ILMN
|
78 M | $ 162.96 | -3.03 % | $ 25.3 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 22.34 | -3.37 % | $ 1.19 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
36.3 M | $ 149.93 | -1.88 % | $ 11.8 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 102.87 | 0.05 % | $ 6.94 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
209 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 11.04 | -2.39 % | $ 1.41 B | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 184.42 | -0.75 % | $ 9.14 B | ||
|
Natera
NTRA
|
15.6 M | $ 218.67 | -1.55 % | $ 29.9 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 456.62 | -0.45 % | $ 13.2 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 151.41 | -2.46 % | $ 23.7 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.7 | 0.11 % | $ 435 M | ||
|
National Research Corporation
NRC
|
451 K | $ 19.4 | -1.77 % | $ 434 M | ||
|
Personalis
PSNL
|
6.89 M | $ 11.42 | -5.62 % | $ 1.02 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 26.22 | 0.87 % | $ 24.9 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.8 | -3.0 % | $ 284 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
726 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.15 | 0.09 % | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 264.51 | 1.3 % | $ 22 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 71.41 | -3.41 % | $ 4.27 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 8.96 | -1.75 % | $ 1.94 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 199.73 | 1.82 % | $ 22.2 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
31.1 M | $ 367.41 | -2.4 % | $ 21.9 B |